Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Annals of Surgical Oncology|December 5, 2002
DNA-PKcs expression in esophageal cancer as a predictor for chemoradiation therapeutic sensitivityTsuyoshi Noguchi, Tomotaka Shibata, Shoichi Fumoto, et al.
Annals of Surgical Oncology|January 30, 2007
Assessment of clinical outcome in patients with esophageal squamous cell carcinoma using TNM classification score and molecular biological classificationShinsuke Takeno, Tsuyoshi Noguchi, Yoshiaki Takahashi, et al.
Expert Opinion on Therapeutic Targets|May 27, 2009
EMP3 as a candidate tumor suppressor gene for solid tumorsShoichi Fumoto, Keiji Tanimoto, Eiso Hiyama, et al.
American Journal of Clinical Pathology|July 27, 2004
E-cadherin expression in patients with esophageal squamous cell carcinoma: promoter hypermethylation, Snail overexpression, and clinicopathologic implicationsShinsuke Takeno, Tsuyoshi Noguchi, Shoichi Fumoto, et al.
Oncology Reports|January 12, 2005
Impact of nuclear galectin-3 expression on histological differentiation and vascular invasion in patients with esophageal squamous cell carcinomaTomotaka Shibata, Tsuyoshi Noguchi, Shinsuke Takeno, et al.
The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai Zasshi|February 4, 2003
Adenosquamous carcinoma arising in Barrett's esophagusTsuyoshi Noguchi, Yuzo Uchida, Shoichi Fumoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2007
[A case of recurrent esophageal cancer successfully treated with concurrent radiochemotherapy with low-dose docetaxel plus 5-FU]Tomotaka Shibata, Shinsuke Takeno, Satoshi Watanabe, et al.
Cancer Letters|October 1, 2008
EMP3 as a tumor suppressor gene for esophageal squamous cell carcinomaShoichi Fumoto, Keiko Hiyama, Keiji Tanimoto, et al.
Plos One|November 15, 2017
A 17-molecule set as a predictor of complete response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancerHajime Fujishima, Shoichi Fumoto, Tomotaka Shibata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 20, 2009
[The effectiveness of S-1 based sequential chemotherapy as second-line treatment for advanced/recurrent gastric cancer]Naotoshi Sugimoto, Hiroyuki Narahara, Daisuke Sakai, et al.
Pageof 3